Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2525)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5695)
  2. Department of Medicine (5685)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (203)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17- demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors
    Journal Article

    Aregbe, A. O.; Sherer, E. A.; Egorin, M. J.; Scher, H. I.; Solit, D. B.; Ramanathan, R. K.; Ramalingam, S.; Belani, C. P.; Ivy, P. S.; Bies, R. R.
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index
    Journal Article

    Ulmert, D.; Kaboteh, R.; Fox, J. J.; Savage, C.; Evans, M. J.; Lilja, H.; Abrahamsson, P. A.; Björk, T.; Gerdtsson, A.; Bjartell, A.; more...
    European Urology (2012)

    Fulltext@MSK | Save
  • A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease
    Journal Article

    Thompson, V. C.; Day, T. K.; Bianco-Miotto, T.; Selth, L. A.; Han, G.; Thomas, M.; Buchanan, G.; Scher, H. I.; Nelson, C. C.; Greenberg, N. M.; more...
    International Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Reply to Giuseppe Procopio, Elena Verzoni and Filippo de Braud's letter to the editor re: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: An exploratory analysis of the outcomes of elderly patients in the RECORD-1 trial. Eur Urol 2012;61:826-33
    Journal Article

    Porta, C.; Motzer, R. J.
    European Urology (2012)

    Fulltext@MSK | Save
  • Temporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASH
    Journal Article

    Han, S.; Paulsen, J. L.; Zhu, G.; Song, Y.; Chun, S.; Cho, G.; Ackerstaff, E.; Koutcher, J. A.; Cho, H.
    Magnetic Resonance Imaging (2012)

    Fulltext@MSK | Save
  • A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen
    Journal Article

    Gregor, P.; Huang, Q. D.; Gallardo, H. F.; Rasalan, T. S.; Morris, M. J.
    Clinical Genitourinary Cancer (2012)

    Fulltext@MSK | Save
  • A dynamic tumor model of the RECORD-1 phase 3 trial in patients with metastatic renal cell carcinoma (mRCC): Quantification of the effect of everolimus on tumor growth and new metastases
    Meeting Abstract

    Stein, A. M.; Carter, A.; Hollaender, N.; Motzer, R.; Sarr, C.
    BJU International (2012)

    Fulltext@MSK | Save
  • Targeting castration resistant prostate cancer (CRPC) with autologous PSMA-directed chimeric antigen receptor T cells
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Olszewska, M.; Taylor, C.; Wasielewska, T.; Bartido, S.; Poon, S.; Scher, H. I.; more...
    Molecular Therapy (2012)

    Fulltext@MSK | Save
  • Relationship between Karnofsky Performance Status (KPS) and tumor response: Analysis of the RECORD-1 phase 3 trial of everolimus in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Porta, C.; Escudier, B.; Hutson, T. E.; Figlin, R.; Calvo, E.; Grünwald, V.; Osanto, S.; Ravaud, A.; Panneerselvam, A.; Knox, J. J.; more...
    BJU International (2012)

    Fulltext@MSK | Save
  • A multicenter, open-label, randomized phase 3 trial comparing the safety and efficacy of dovitinib (TKI258) versus sorafenib in patients with metastatic renal cell carcinoma after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor) therapies
    Meeting Abstract

    Motzer, R.; Sternberg, C. N.; Vogelzang, N.; Urbanowitz, G.; Cai, C.; Kay, A.; Escudier, B.
    BJU International (2012)

    Fulltext@MSK | Save